These developments underscore a broader trend where obesity medicines are evolving into whole-body therapies with implications across multiple disease states
AbbVie and Genmab made their case for Epkinlys approval with data from the Phase I/II EPCORE NHL-1 trial, where the drug elicited an objective response rate of 82%, including a 60% complete response rate and a 22% partial response rate
Cloudiness or visible specks usually mean the peptide has not fully dissolved
Each plan is reviewed for caloric adequacy, macronutrient balance, and real-world usability." Those specialized meal plans address a range of needs, including options for those managing diabetes, those on GLP-1 medications, Mediterranean-style eating, and higher-protein approaches
Deficiencies in key nutrients can impair metabolic function in ways that contribute to stalls